Fundz

Apnimed reported raising $150 Million in an initial SEC Form D filing, from an offering of $25 Million

PUBLIC · APMDMar 27, 2026

Amount Raised

$150 Million

$150 Million per company press release (Apr 6, 2026)

Round Type

Debt Financing

CambridgeManufacturingHealthcare

Investors

HealthCare Royalty Partners

Description

Apnimed, Inc. has entered into a senior secured credit facility for up to $150 million with HealthCare Royalty Partners. The capital will support the commercial readiness activities for the planned U.S. launch of AD109, pending FDA approval

Quick answer

Apnimed raised $150 Million in a Debt Financing round, dated March 11, 2026. Investors: HealthCare Royalty Partners. Apnimed is based in Cambridge, Massachusetts, United States.

How much did Apnimed raise?
Apnimed raised $150 Million in a Debt Financing round on March 11, 2026.
Who invested in Apnimed?
HealthCare Royalty Partners is named as investors in this round.
What does Apnimed do?
Apnimed is a clinical-stage pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea – patients with obstructive sleep apnea could benefit from treatment with a safe and effective..
Where is Apnimed based and how big is it?
Apnimed is based in Cambridge, Massachusetts, United States. Fundz records about 82 employees.
Who are the decision-makers at Apnimed?
Fundz holds 1 contact at Apnimed. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Manufacturing around the same time

Companies in the same sectors as Apnimed that raised within 45 days of this round, from Fundz verified event records.

  • Lucid Group raised $1.1B (Post-IPO Equity) on April 15, 2026.
  • Route 92 Medical raised $50M (Funding Round) on April 7, 2026.
  • Monteris Medical raised $28M (Series E) on March 12, 2026.
  • Tenon Medical raised $4.3M on March 11, 2026.
  • Cognito Therapeutics raised $105M (Series C) on March 5, 2026.
  • Doc.com raised $1.5M (Seed) on February 2, 2026.

Who to call at Apnimed, and when

A new round usually means Apnimed is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Apnimed raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Apnimed, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Apnimed. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Apnimed

Location

39 John F. Kennedy Street, 4th Fl

Cambridge, Massachusetts, United States

About

Apnimed is a clinical-stage pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea – patients with obstructive sleep apnea could benefit from treatment with a safe and effective oral medication dosed once daily at bedtime. Apnimed’s lead development program targets the neurologic control of upper airway muscles to maintain an open airway during sleep. Based in Cambridge, Mass., the company is developing a portfolio of novel pharmacologic therapies for sleep apnea and related disorders. Learn more at apnimed.com or follow us on Twitter and LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Apnimed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts24 people are listed at Apnimed. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Apnimed's next move

See what Strategic adds

Apnimed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.